Association of

Alzheimer's disease MME Neprilysin SNP polymorphism

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 27 05 2024
revised: 04 09 2024
accepted: 05 09 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: epublish

Résumé

the This case-control study comprised 120 AD-diagnosed patients and 120 healthy individuals without any prior family history of AD. The patient and control groups were matched for major demographic and health characteristics. Genotyping was performed by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). All patients included in this study were assessed by an experienced neurologist to exclude cases with other forms of dementia based on a brain computed tomography scan and other clinical findings. There were no significant differences in demographic and health characteristics including sex, diabetes, blood pressure, and cigarette smoking status between case and control groups (p > 0.05). However, the age difference appeared significant. Both SNPs were significantly associated with the risk of AD in our study population. The rs3736187 (T > C, 3:155168489) was strongly associated with AD risk under the log-additive model (OR = 1.67, CI = 1.18-2.37, p-value = 0.003). The rs6797911 (T > A, 3:155144601) also showed a significant association with AD risk under the dominant model (TT vs. TA and AA, OR = 3.37, CI = 1.86-6.1, p-value <0.001). There is a strong association between

Sections du résumé

Background UNASSIGNED
the
Methods UNASSIGNED
This case-control study comprised 120 AD-diagnosed patients and 120 healthy individuals without any prior family history of AD. The patient and control groups were matched for major demographic and health characteristics. Genotyping was performed by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR).
Results UNASSIGNED
All patients included in this study were assessed by an experienced neurologist to exclude cases with other forms of dementia based on a brain computed tomography scan and other clinical findings. There were no significant differences in demographic and health characteristics including sex, diabetes, blood pressure, and cigarette smoking status between case and control groups (p > 0.05). However, the age difference appeared significant. Both SNPs were significantly associated with the risk of AD in our study population. The rs3736187 (T > C, 3:155168489) was strongly associated with AD risk under the log-additive model (OR = 1.67, CI = 1.18-2.37, p-value = 0.003). The rs6797911 (T > A, 3:155144601) also showed a significant association with AD risk under the dominant model (TT vs. TA and AA, OR = 3.37, CI = 1.86-6.1, p-value <0.001).
Conclusion UNASSIGNED
There is a strong association between

Identifiants

pubmed: 39309779
doi: 10.1016/j.heliyon.2024.e37556
pii: S2405-8440(24)13587-6
pmc: PMC11416268
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e37556

Informations de copyright

© 2024 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fereshteh Khalili-Moghadam (F)

Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Javad Hosseini Nejad (J)

Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Taleb Badri (T)

Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Morteza Sadeghi (M)

Human Genetics Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Javad Gharechahi (J)

Human Genetics Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Classifications MeSH